Propósito

✔ Brazil SFE® Pharma Produtivity, Effectiveness, CRM, BI, SFE, ♕Data Science Enthusiast, ✰BI, Big Data & Analytics, ✰Market Intelligence, ♕Sales Force Effectiveness, Vendas, Consultores, Comportamento, etc... Este é um lugar onde executivos e profissionais da Indústria Farmacêutica atualizam-se, compartilham experiências, aplicabilidades e contribuem com artigos e perspectivas, ideias e tendências. Todos os artigos e séries são desenvolvidos por profissionais da indústria. Este Blog faz parte integrante do grupo AL Bernardes®.

🌸 2021 - English

🌸 2021 - English#BrazilSFE #PharmaceuticalIndustry   #2021

Below you will find all the articles that have the year reference in their titles.



All publications with data referring to  2021:



Yes, we know, we know, we know…

Seeing this message is annoying. We know. (Imagine writing it...)  But it's also incredibly important. One of  ✔ Brazil SFE® 's greatest strengths is its partially reader-funded model.  


1. Reader funding means we can cover whatever we want. We're not subject to the whims of a billionaire owner. No one can tell us what not to say or what not to report.


2. Reader funding means we don't have to chase clicks and traffic. We don't desperately seek your attention for its own sake: we seek out the stories our editorial team considers important and worthy of your time.


3. Reader funding means we can keep our blog open, allowing as many people as possible to read quality articles from around the world.


The support of readers like you makes all of this possible. Currently, only 2.4% of our regular readers help fund our work. If you want to help protect our editorial independence, consider joining us today.


We appreciate any donation, but a monthly donation makes the biggest impact, allowing us to invest more in our most crucial and fearless work. So we hope you'll consider supporting us. Thank you!

👉 Follow  André Bernardes  on LinkedIn .  Click here to contact me via WhatsApp.

Comment and share this article! 

brazilsalesforceeffectiveness@gmail.com

 

 Articles     

 

 

 DOL | Digital Digital Opinion Leader

Pharmaceutical Industry
Tags: ,

Nenhum comentário:

Postar um comentário

Compartilhe sua opinião e ponto de vista:

Assinar: Postar comentários (Atom)